Bertrand NADEL
PhD
-
Canceropôle PACA Director | Leader of the team "Genomic instability and human hemopathies" at the CIML
CIML, Canceropôle PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.
#clinique #rechercheHave a look on our testimonies
MI COMMUNITY
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.
Christian CHABANNON
AMU, IPC, AP-HM, Inserm
MI COMMUNITY
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.
Fabrice BARLESI
AMU, Gustave Roussy, The Pioneer Project
MI COMMUNITY
Immunotherapy is expanding to other cancers types: kidney cancer, bladder cancer, hepatocellular carcinoma, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma… but we are still only at the beginning of the story!
Mondher MAHJOUBI
Innate Pharma
MI COMMUNITY
Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research.
Catherine FARNARIER
AP-HM
MI AND YOU Show
your commitment to MI
your commitment to MI